Drew Spaventa

Board Member at Aspen Neuroscience

Drew Spaventa is CEO and Founder of Singular Genomics and works as a Managing Partner at Axon Ventures. Mr. Spaventa is also a founder of Truvian Sciences. He was a seed investor and consultant for Corporate Development and Strategy at Edico Genome which was acquired by Illumina in 2018 and a seed investor and part of the founding team for ecoATM which was acquired by Outerwall (Coinstar) in 2012. Mr. Spaventa is a member of the Board of the San Diego Venture Group. He received his Master’s degree in Business Administration and Finance from the University of California, San Diego – Rady School of Management. He also attended University of California San Diego where he obtained his Bachelor’s degree in Political Science and International Relations.


  • Board Member

    Current role